International Society for Clinical Biostatistics

International Society for Clinical Biostatistics
Name	International Society for Clinical Biostatistics
Abbrev	ISCB
Formation	1978
Type	Professional association
Headquarters	Copenhagen
Region served	International
Leader title	President

Contents

International Society for Clinical Biostatistics is a professional association focused on the development and application of statistical methods in clinical research and medical trials. It brings together statisticians, epidemiologists, clinicians, and methodologists from institutions such as University of Oxford, Karolinska Institute, Harvard University, Johns Hopkins University, and Imperial College London to advance standards in trial design, data analysis, and regulatory science. The Society fosters exchange among members affiliated with organizations like European Medicines Agency, Food and Drug Administration (United States), World Health Organization, and academic centers including University of Cambridge, University of Copenhagen, and Utrecht University.

History

The Society was founded amid developments in clinical trial methodology influenced by figures and events tied to Richard Doll, Austin Bradford Hill, Ronald Fisher, Cochrane Collaboration, and the rise of randomized controlled trials after the Second World War. Early meetings featured participants from London School of Hygiene and Tropical Medicine, Beth Israel Deaconess Medical Center, Mayo Clinic, Karolinska Institute, and University of Edinburgh and responded to regulatory initiatives by European Medicines Agency and policy trends prompted by the Tuskegee syphilis study revelations and the Declaration of Helsinki. Over subsequent decades, the Society interacted with networks including International Statistical Institute, Royal Statistical Society, American Statistical Association, Institute of Mathematical Statistics, and Society for Clinical Trials to harmonize methods, echoing guideline efforts similar to those by CONSORT authors and contributors associated with Lancet and New England Journal of Medicine editorial boards.

The Society’s mission aligns with priorities advocated by bodies such as World Health Organization, UNICEF, European Commission, and National Institutes of Health to improve clinical research quality. Objectives include promoting methodological research resonant with the agendas of Clinical Trials (journal), supporting training initiatives paralleling programs at Johns Hopkins Bloomberg School of Public Health and University of Washington, and contributing expertise relevant to standards from International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and regulatory authorities like Food and Drug Administration (United States). The Society emphasizes transparency consonant with practices endorsed by BMJ, PLOS Medicine, and international ethics frameworks exemplified by the Declaration of Helsinki and guidance from Council for International Organizations of Medical Sciences.

Membership comprises professionals connected to institutions such as University of Basel, University of Toronto, McGill University, ETH Zurich, and National University of Singapore, including researchers affiliated with GlaxoSmithKline, Roche, Pfizer, and AstraZeneca. Governance structures mirror those of associations like American Statistical Association and International Biometric Society with elected officers, an executive committee, and specialized working groups similar to committees in European Society for Medical Oncology and International Society for Pharmacoepidemiology. Leadership roles have been held by scholars who have also contributed to panels at World Health Organization consultations and advisory boards for journals such as Statistics in Medicine and Trials.

The Society organizes biennial meetings that draw speakers and attendees from universities and organizations including Harvard Medical School, Stanford University, Columbia University, National Institutes of Health, and European Medicines Agency. Sessions often feature methodological presentations that reference work by researchers associated with Cochrane Collaboration, CONSORT Group, TRIPOD Initiative, and landmark trials published in The Lancet and New England Journal of Medicine. Meetings have included satellite workshops with collaborators like International Society for Pharmacoepidemiology, Society for Clinical Trials, Royal Statistical Society, and specialty groups affiliated with American Heart Association and European Respiratory Society.

The Society supports dissemination through proceedings and working papers comparable to outputs of International Statistical Review and Statistics in Medicine, and it coordinates short courses and summer schools modeled after programs at European University Institute and Johns Hopkins Bloomberg School of Public Health. Educational activities cover topics prominent in literature from BMJ, PLOS Medicine, Nature Medicine, and methodological texts used at University of Oxford and University of Cambridge, addressing issues raised by regulators such as European Medicines Agency and Food and Drug Administration (United States). The Society’s materials inform guideline development processes similar to those led by CONSORT and STROBE groups and contribute to capacity building in regions represented by World Health Organization offices.

The Society collaborates with professional bodies including International Statistical Institute, Royal Statistical Society, American Statistical Association, International Biometric Society, and clinical research networks such as European Clinical Research Infrastructure Network and ClinicalTrials.gov stakeholders. Partnerships extend to academic institutions like University of Manchester, King's College London, Erasmus University Rotterdam, and policy organizations including WHO and European Commission research programs. Joint initiatives have involved guideline development comparable to projects by CONSORT and cooperative workshops with funders like Wellcome Trust, Bill & Melinda Gates Foundation, and National Institutes of Health.

Category:Biostatistics organizations